MIP
AZN icon

Marietta Investment Partners’s AstraZeneca AZN Stock Holding History

Marietta Investment Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
+7,929
New +$1.49M 0.26% 78
2025
Q4 		– Sell
-6,092
Closed -$935K – 164
2025
Q3 		$935K Sell
6,092
-23
-0.4% -$3.48K 0.18% 97
2025
Q2 		$855K Buy
6,115
+468
+8% +$65.6K 0.19% 98
2025
Q1 		$830K Sell
5,647
-7
-0.1% -$1.01K 0.2% 90
2024
Q4 		$741K Sell
5,654
-1,311
-19% -$184K 0.16% 101
2024
Q3 		$1.09M Sell
6,965
-5
-0.1% -$807 0.23% 81
2024
Q2 		$1.09M Sell
6,970
-5
-0.1% -$752 0.24% 78
2024
Q1 		$945K Sell
6,975
-1,366
-16% -$181K 0.21% 88
2023
Q4 		$1.12M Sell
8,341
-30,719
-79% -$3.99M 0.28% 78
2023
Q3 		$5.29M Sell
39,060
-2
-0% -$273 1.48% 21
2023
Q2 		$5.59M Buy
39,062
+31,045
+387% +$4.57M 1.45% 23
2023
Q1 		$1.11M Sell
8,017
-143
-2% -$19.2K 0.31% 66
2022
Q4 		$1.11M Buy
8,160
+129
+2% +$16.2K 0.31% 68
2022
Q3 		$980K Buy
8,031
+49
+0.6% +$6.22K 0.29% 68
2022
Q2 		$1.05M Buy
7,982
+694
+10% +$91.1K 0.31% 70
2022
Q1 		$967K Buy
7,288
+1,588
+28% +$190K 0.22% 87
2021
Q4 		$664K Hold
5,700
– – 0.14% 112
2021
Q3 		$685K Hold
5,700
– – 0.16% 107
2021
Q2 		$683K Sell
5,700
-108
-2% -$11.8K 0.16% 104
2021
Q1 		$577K Buy
5,808
+250
+4% +$25.1K 0.14% 108
2020
Q4 		$556K Sell
5,558
-8,069
-59% -$855K 0.14% 101
2020
Q3 		$1.49M Buy
13,627
+395
+3% +$43.9K 0.45% 47
2020
Q2 		$1.4M Buy
13,232
+8,583
+185% +$886K 0.47% 49
2020
Q1 		$415K Buy
4,649
+1,432
+45% +$135K 0.18% 83
2019
Q4 		$321K Buy
+3,217
New +$303K 0.1% 126

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $148B AUM
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marietta Investment Partners's AZN Position: Q2 2026 in Review

Marietta Investment Partners opened a new position in AstraZeneca (AZN) in Q2 2026: 7,929 shares worth $1.5M. The stake represents 0.26% of the portfolio and ranks #78 among its holdings. This is a return to the name: Marietta Investment Partners previously reported a position in AZN as recently as Q3 2025.

Marietta Investment Partners first reported a position in AZN in Q4 2019 and has held it in 25 quarters since. The position peaked at $5.59M in Q2 2023. 1,329 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Marietta Investment Partners held 7,929 shares of AstraZeneca worth $1.5M as of Q2 2026.
  • AstraZeneca was a new Marietta Investment Partners position in Q2 2026.
  • AstraZeneca made up 0.26% of Marietta Investment Partners's portfolio in Q2 2026, its #78 holding.
  • Marietta Investment Partners first reported a position in AstraZeneca in Q4 2019 and has held it in 25 quarters since.
  • Marietta Investment Partners's AstraZeneca position peaked at $5.59M in Q2 2023.
  • 1,329 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Marietta Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.